Proxy Sets Company on a Path to Attract the Optimal Crypto Treasury Strategy Increase in Authorized Shares to 1 Billion Would Position the Company to Attract Industry-Leading Market Participants and ...

ProPhase Labs’ valuable subsidiaries, their synergies, and significant growth underscore our potential for long-term value. www.ProPhaseLabs.com Forward-Looking Statements ...

"Our Board remains focused on strengthening ProPhase Labs’ ability to innovate, reward talent, and create value for our shareholders,” said Ted Karkus, Chairman and Chief Executive Officer of ProPhase ...

Financing provides bridge to multiple potentially significant liquidity events and crypto strategies UNIONDA ...

We use cookies and other tracking technologies to improve your browsing experience on our website, to show you personalized content and targeted ads, to analyze our website traffic, and to understand ...

UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH), a biotech company with a market capitalization of $15.18 million, announced Monday that its Board of Directors has authorized management to ...

UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH), currently trading at $0.39 per share with a market capitalization of $16.22 million, announced Wednesday it has closed a $3 million private ...

UNIONDALE, NY - ProPhase Labs, Inc. (NASDAQ:PRPH), a biotech company with a market capitalization of $15.18 million, announced Monday that its Board of Directors has authorized management to explore a ...

Financing provides bridge to multiple potentially significant liquidity events and crypto strategies UNIONDALE, NY, July 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the "Company" ...

UNIONDALE, NY, July 21, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), (the “Company” or “ProPhase”) a next generation biotech, genomics and consumer products company, today announced ...

Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to break-even earnings per share a ...